Soft Tissue Volume Gain and Stability Comparing Palate and Tuberosity
NCT ID: NCT03090906
Last Updated: 2017-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
32 participants
INTERVENTIONAL
2015-04-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants.
NCT04766255
Peri-implant Tissue Stability Following Tissue Augmentation Harvested From Deep Palate or Tuberosity
NCT05014763
Soft Tissue Volume Changes After Immediate Implants With Two Different Techniques
NCT04803110
Vertical Soft Tissue Augmentation With Tent Pole Technique and Its Influence on Marginal Bone Loss Around Dental Implants
NCT07018531
Effect of Xenogeneic Collagen Matrix on the Peri-implant Tissues of Immediate Implants.
NCT04980313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main goal of this study is to compare the soft tissue volume gain and stability around implants in cases where a SCTG of the same dimensions from the P or T is used randomly. To calculate volume changes and stability an intraoral optical scan is used and three-dimensional images superimposed.
The secondary goal is to compare histologically both tissues and changes in clinical parameters. Histomorphometry and immunohistochemistry evaluating levels of Type I-III collagen, long lysyl hydroxylase, matrix metalloproteinase 1-2, and monoclonal antibody against cytokeratin 4-10-13 is performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group: SCTG from palate
Soft tissue augmentation palate
Soft tissue augmentation palate
Recipient site: Intrasulcular incision at the buccal side of the implant extending in one adjacent tooth for each side and a partial-thickness mucosal flap raised. The connective tissue was secured with suture. Allocation to either treatment was performed according to a randomization table.
Donor site A double-bladed scalpel handle 1,5mm was used in both areas to obtain the same thickness.
Palate (CG) The double incision was made approximately 2 to 3 mm apical to the gingival margins of premolars. The donor tissue was removed and cross-mattress sutures were used to approximate the wound on the palate.
In both groups the epithelial collar removed. Graft required dimensions for both groups:10mm height, 12mm length and 1,5mm thick.
Intraoral optical scan
Intraoral optical scan was performed at both groups at baseline, 3 months, 4 months and 12 months to be able to compare volumetric changes.
Test group: SCTG from tuberosity
Soft tissue augmentation tuberosity
Soft tissue augmentation tuberosity
Recipient site: Intrasulcular incision at the buccal side of the implant extending in one adjacent tooth for each side and a partial-thickness mucosal flap raised. The connective tissue was secured with suture. Allocation to either treatment was performed according to a randomization table.
Donor site A double-bladed scalpel handle 1,5mm was used in both areas to obtain the same thickness.
Tuberosity (TG) The double incision was made from the distal of the terminal tooth. A second incision was made perpendicular to the linear incision at a distal point, which joined the two linear incisions. The graft was removed and a crossed horizontal suspension suture was used.
Epithelial collar removed. Graft required dimensions for both groups:10mm height, 12mm length and 1,5mm thick.
Intraoral optical scan
Intraoral optical scan was performed at both groups at baseline, 3 months, 4 months and 12 months to be able to compare volumetric changes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soft tissue augmentation palate
Recipient site: Intrasulcular incision at the buccal side of the implant extending in one adjacent tooth for each side and a partial-thickness mucosal flap raised. The connective tissue was secured with suture. Allocation to either treatment was performed according to a randomization table.
Donor site A double-bladed scalpel handle 1,5mm was used in both areas to obtain the same thickness.
Palate (CG) The double incision was made approximately 2 to 3 mm apical to the gingival margins of premolars. The donor tissue was removed and cross-mattress sutures were used to approximate the wound on the palate.
In both groups the epithelial collar removed. Graft required dimensions for both groups:10mm height, 12mm length and 1,5mm thick.
Soft tissue augmentation tuberosity
Recipient site: Intrasulcular incision at the buccal side of the implant extending in one adjacent tooth for each side and a partial-thickness mucosal flap raised. The connective tissue was secured with suture. Allocation to either treatment was performed according to a randomization table.
Donor site A double-bladed scalpel handle 1,5mm was used in both areas to obtain the same thickness.
Tuberosity (TG) The double incision was made from the distal of the terminal tooth. A second incision was made perpendicular to the linear incision at a distal point, which joined the two linear incisions. The graft was removed and a crossed horizontal suspension suture was used.
Epithelial collar removed. Graft required dimensions for both groups:10mm height, 12mm length and 1,5mm thick.
Intraoral optical scan
Intraoral optical scan was performed at both groups at baseline, 3 months, 4 months and 12 months to be able to compare volumetric changes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Implant must be located between 2 fixed reference points i.e. clinical crowns.
* All implants locations with a need of a soft tissue volume augmentation.
* Palate must have ≥2mm of thickness at premolar area.
* Tuberosity \> 12mm in length.
* Full mouth plaque and bleeding score \<20%.
Exclusion Criteria
* Heavy Smokers (\> 10 cigarettes per day).
* Local or systemic conditions that would interfere with routine periodontal therapy (non controlled diabetes, liver function disorder, immunosuppressant disease, autoimmune disease).
* Allergy to Non-Steroidal Anti-Inflammatory Drugs.
* Patients taking medications that cause gingival enlargement
* Gingival idiopatic overgrowth
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Osteology Foundation
OTHER
Universitat Internacional de Catalunya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ernest Rojo Xicart
Professor Section of Periodontology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PER- ECL-2011-10-NF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.